Relationships Between Physical Activity and Inhibitory Control Among College Students

NCT ID: NCT06472960

Last Updated: 2024-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this study is to explore the impact of a 20-minute aerobic exercise on inhibitory control, microvascular diameters, and brain function. The main questions it aims to answer are:

1. Is there a correlation among the level of physical activity, performance in inhibitory control, and the diameter of retinal microvasculature, and do retinal microcirculation parameters mediate this relationship?
2. Does short-term aerobic exercise (moderate and high intensity) improve inhibitory control and physiological markers, such as retinal diameter and frontal brain activation, compared to a sedentary control group?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Moderate-intensity cycling

Moderate-intensity cycling on Ergoline Ergoselect 100

Group Type EXPERIMENTAL

Moderate-intensity cycling

Intervention Type BEHAVIORAL

Moderate-intensity cycling on Ergoline Ergoselect 100

Uninterrupted sitting

Intervention Type BEHAVIORAL

Uninterrupted sitting in a quiet room

Vigorous-intensity cycling

Vigorous-intensity cycling on Ergoline Ergoselect 100

Group Type EXPERIMENTAL

Vigorous-intensity cycling

Intervention Type BEHAVIORAL

Vigorous-intensity cycling on Ergoline Ergoselect 100

Uninterrupted sitting

Intervention Type BEHAVIORAL

Uninterrupted sitting in a quiet room

Uninterrupted sitting

Uninterrupted sitting in a quiet room

Group Type EXPERIMENTAL

Uninterrupted sitting

Intervention Type BEHAVIORAL

Uninterrupted sitting in a quiet room

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Moderate-intensity cycling

Moderate-intensity cycling on Ergoline Ergoselect 100

Intervention Type BEHAVIORAL

Vigorous-intensity cycling

Vigorous-intensity cycling on Ergoline Ergoselect 100

Intervention Type BEHAVIORAL

Uninterrupted sitting

Uninterrupted sitting in a quiet room

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* right-handed (how was handedness assessed; i.e., "What hand do you write with?") with normal or corrected-to-normal vision and normal color vision

Exclusion Criteria

* reported a history of cardiovascular, metabolic, gastrointestinal, neurological, or psychiatric disorders, medical conditions requiring medical care, substance addiction, strict diets (e.g., low- carbohydrate and Mediterranean diet), pregnancy, or lactation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shenzhen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Liye Zou

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Body-Brain-Mind Laboratory, School of Psychology, Shenzhen University

Shenzhen, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liye Zou, Dr.

Role: CONTACT

18823437684

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liye Zou, Dr.

Role: primary

18823437684

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SZUPaIntervention

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Circuit Training and Retina
NCT05714813 COMPLETED NA